Ignite Creation Date:
2024-10-25 @ 8:04 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06581458
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-03
Brief Title:
Home Transcranial Direct-Current Stimulation for Motoric Cognitive Risk Syndrome
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Home Transcranial Direct-Current Stimulation for Motoric Cognitive Risk Syndrome
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HometDCS
Brief Summary:
1 To examine the effect of a two-week tDCS intervention of 3 months of continued tDCS intervention versus 3 months of receiving a placebo treatment dummy On the costs of performing an action task dual task cost walking speed cognitive measures and motor function
2 To examine whether the effects of tDCS build up over time by creating a delayed start mechanism in the intervention delayed-start design
3 Examining mechanical and neuroplastic effects of tDCS intervention
4 To examine the response to tDCS over time
2 To examine whether the effects of tDCS build up over time by creating a delayed start mechanism in the intervention delayed-start design
3 Examining mechanical and neuroplastic effects of tDCS intervention
4 To examine the response to tDCS over time
Detailed Description:
The study aims to investigate the mechanical and neuroplastic effects of a tDCS intervention
The intervention consists of an initial two-week period of tDCS application followed by three months of continued tDCS treatment
A placebo group will receive a dummy treatment for three months to compare the outcomes
The study will measure various parameters including the costs of performing an action task dual task cost walking speed cognitive measures and motor function
A delayed-start design will be used to determine if the effects of tDCS build up over time
The intervention consists of an initial two-week period of tDCS application followed by three months of continued tDCS treatment
A placebo group will receive a dummy treatment for three months to compare the outcomes
The study will measure various parameters including the costs of performing an action task dual task cost walking speed cognitive measures and motor function
A delayed-start design will be used to determine if the effects of tDCS build up over time
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None